1. Introduction
α-Amanitin is the most toxic toxin in
Amanita phalloides, with a lethal dose to humans being around 0.1 mg/kg [
1], its chemical structure is shown in
Figure S1 [
2]. α-Amanitin is rapidly absorbed from the gastrointestinal tract into the blood after poisoning [
3]. It can then be transported to organs like the liver and kidneys, causing hepatic and renal damage [
1]. Early blood detection of α-amanitin enables timely intervention. Thus, developing a highly specific technique for detecting α-amanitin in blood is crucial for early diagnosis.
The detection techniques currently used for the plasma or serum of α-amanitin mainly include liquid chromatography-tandem mass spectrometry (LC-MS/MS), molecularly imprinted sensors, immunosensors, and enzyme-linked immunosorbent assays (ELISA) [
4,
5,
6,
7]. LC-MS/MS offers high sensitivity and specificity for individual analytes, but this method requires trained personnel and uses expensive instruments. Molecularly imprinted sensors have exhibited high selectivity for α-amanitin. Yet template leakage risks affect detection accuracy. Immunosensors using monoclonal antibodies against α-amanitin, which can specifically detect both α-amanitin and β-amanitin simultaneously. Nevertheless, the preparation of such monoclonal antibodies is technically challenging, costly, and time-consuming. Additionally, a commercial ELISA kit that is available year-round enables the detection of α-amanitin and γ-amanitin down to 0.2 ng/mL, demonstrating high selectivity. ELISA does not require expensive laboratory equipment; however, it remains limited in preparing monoclonal antibodies against small molecules such as α-amanitin. Despite progress in α-amanitin blood detection, a method that is easy to operate, prepare, low-cost, portable, and highly sensitive and specific is still lacking. Fortunately, aptamers offer a new opportunity for developing α-amanitin detection technology.
Aptamers have a lot of special advantages, including facile chemical synthesis and modifications, high stability and specificity, cost-effective production, and adaptability to test strips [
8]. They are widely applied in biochemical analysis, specifically in toxin detection [
9,
10,
11]. Notably, aptamers require a thermal denaturation step to eliminate non-specific secondary structures. This step relies on heating appliances and adds an incubation step. Optimizing the aptamer sequence reduces its dependence on thermal folding and further enhances its applicability for portable instruments. High-affinity aptamer selection is crucial for specific detection technologies. However, selecting aptamers for small molecules like α-amanitin (918.97 Da) is harder than for large molecules such as proteins [
12,
13,
14]. Their small size significant reduces molecular mass differences between aptamer-target complexes and unbound sequences; their simple structures offer fewer binding sites and weak aptamer interactions, complicating complex separation [
12,
14]. Thus, small-molecule aptamer selection typically requires immobilizing the target on solid substrates, like beads [
15], microplate wells [
16], and columns [
17]. For example, Strzałka et al. covalently immobilized modified α-amanitin on cyanogen bromide-activated Sepharose 4B, then selected aptamers with a dissociation constant (K
d) of 5.026 ± 0.69 μM [
18]. Yet small molecule targets often lack functional groups for coupling to solid surfaces, even feasible immobilization may alter the target’s natural structure or block critical binding sites due to chemical modifications during immobilization, reducing affinity [
19].
An alternative small-molecule aptamer selection strategy is library-immobilized SELEX, which avoids small-molecule conjugation by immobilizing the library onto the substrate via complementary base pairing. For instance, Li et al. proposed a novel library-immobilized SELEX using positively charged gold nanoparticles to select an α-amanitin aptamer [
20]. This method has successfully selected aptamers for small molecules like polymyxin B and spermidine [
21,
22]. Nevertheless, this approach suffers from low enrichment. Immobilized libraries may undergo dynamic dissociation due to weak internal base pairing, causing some unbound sequences to detach from the support and leading to false positives. Additionally, library abundance may decrease, and diversity cannot be guaranteed during selection [
23]. In short, both strategies have limitations when used alone for selecting aptamers with affinity for small molecules.
In the study, our goal was to develop a strategy combining target-immobilized and library-immobilized SELEX for aptamer selection, aiming to maximize library diversity and stability via target-immobilized SELEX while minimizing the impact of the target’s natural conformational changes on selection results through library-immobilized SELEX. Initially, retain maximal abundance of enriched sequences using target-immobilized SELEX, then combine affinity candidate sequences with a new random library to form a combinatorial library, and finally conduct library-immobilized SELEX for further selection to obtain aptamers with strong affinity and high specificity.
Aptamer-based specific detection technologies require not only high-affinity aptamers but also overcoming interference in complex biological matrices in practical detection. Current α-amanitin detection methods are mainly applied to mushroom or spiked urine samples [
24,
25]. In 2022, Li et al. developed an electrochemical sensor with gold-graphene quantum dot nanohybrid and DNA cyclic dual-signal amplification, enabling the detection of spiked α-amanitin isolated from blood samples [
26]. Nevertheless, highly specific α-amanitin detection in blood remains challenging due to HSA, which accounts for approximately 60% of total plasma proteins [
27]. With multiple binding sites and strong adsorption, HSA causes non-specific aptamer binding, compromising detection accuracy. Thus, in this study, HSA-modified tosyl-activated magnetic beads were used for counter-selection to reduce non-specific binding from HSA.
The α-amanitin aptamer selection process is shown in
Figure 1. α-amanitin was immobilized onto tosyl-activated magnetic beads. The random library was mixed with the α-amanitin-bead solution, and ssDNA bound to the target was obtained by magnetic separation and amplified for multiple rounds. From the 4th round, counter selection was conducted every two rounds to remove sequences bound to HSA. After 14 rounds, high-throughput sequencing (HTS) was performed on enriched ssDNA libraries from rounds eight and fourteen of target-immobilized SELEX, identifying high-affinity aptamer candidates. Then, the initial ssDNA library selected from target-immobilized SELEX was mixed with new random sequences to form a new combinatorial library; hybrids of this ssDNA combinatorial library and biotin-modified oligonucleotides were incubated with streptavidin magnetic beads for library immobilization. α-amanitin solution was then added to incubate with the library, forming the librarytarget. The librarytarget was subsequently amplified and prepared as ssDNA to obtain a secondary library. After five rounds, we analyzed homology, secondary structures, and preliminarily evaluated affinities of the aptamer candidates. Finally, we used HSA as a counter-selection target to evaluate the specificity of aptamer, since HSA is the most abundant protein in human serum.
3. Conclusions
In this study, we successfully utilized a combined approach of target-immobilized SELEX and library-immobilized SELEX to select high-affinity and specific aptamers for the small-molecule α-amanitin. Tosyl-activated magnetic beads and streptavidin beads were employed as separation matrices to perform target-immobilized and library-immobilized selection of the aptamer. Through stringent control of selection conditions, ssDNA sequences with strong binding affinity to α-amanitin were progressively retained. The enrichment of ssDNA sequences increased with each selection round, and the combination of both methods significantly enhanced the selection efficiency. In the target-immobilized SELEX, following fourteen selection rounds with α-amanitin as the target, eleven candidate sequences with binding activity were preliminarily identified. Among them, the representative candidate sequences, designated as Seq14-1 and Seq14-2, exhibited binding affinity to α-amanitin with Kd values of 1.88 mM and 1.85 mM, respectively. Subsequently, nine candidate sequences were selected after five rounds of selection in the library-immobilized SELEX. The secondary structures of these nine sequences were classified into three families based on their structural similarities. From each family, representative sequences with lower ΔG values were selected as candidate sequences, leading to the identification of four novel aptamers. Among these, Aptamer Seq78-4 exhibited the highest affinity, with a dissociation constant (Kd) in the nanomolar range of 57.80 ± 1.001 nM. Furthermore, in terms of counter-selection, aptamer Seq78-4 exhibited significantly higher specificity toward α-amanitin than toward HSA, thus reducing non-specific binding associated with HSA. This work will offer insights for developing aptamer-based sensors for α-amanitin detection and offer a novel strategy for the selection of aptamers against small-molecule targets.
4. Materials and Methods
4.1. Chemicals and Reagents
4.2. Selection of the α-Amanitin Aptamer
The target-immobilized SELEX was first used for preliminary screening to enrich aptamer candidates that can specifically bind to α-amanitin and retain maximal abundance of enriched sequences. Firstly, 165 μL of tosyl-activated magnetic beads (loading > 20 μg/mg) were washed and placed in a centrifuge tube, followed by the addition of 125 μL of 700 nM α-amanitin. The mixture was then incubated in coupling buffer at 37 °C for 16–24 h to form an α-amanitin bead solution. Second, a blank control group of α-amanitin incubated with coupling buffer only and a conditional control group of human serum protein (HSA)-modified tosyl-activated magnetic beads were set up under the same conditions. After incubation, PBS with bovine serum albumin (BSA) was added to each group for blocking.
The 500 μL 800 nM library (library sequence: 5′-GGGGAGCTCAGAATAAACGCAA-35N-TTCGACATGAG-3′GCCCGGATC) was incubated with 400 μL α-amanitin-bead solution in a DNA LoBind tube (Eppendorf AG, Hamburg, Germany)at 25 °C for 60 min. After incubation, the tube was placed on a magnetic separator, the supernatant was subsequently discarded, and the precipitate was collected for PCR amplification. We prepared a 50 μL PCR reaction mixture containing 2.5 μL each of the forward primer (GGGAGCTCAGAATAAACGCTCAA) and reverse primer (biotin-GATCCGGGGCCTCATGTCGAA) working stocks, 25 μL of 2× Taq Master Mix buffer, 15 μL of nuclease-free water, and 5 μL of template.
The PCR conditions were as follows: reaction cycles 20 times, 95 °C pre-denaturation for 3 min, 94 °C denaturation for 30 s, 54–61 °C annealing for 1 min, 72 °C extension for 1 min 30 s, 72 °C final extension 5 min, 4 °C hold. Meanwhile, a no-template control group was set up, in which the sample template DNA was replaced with ultrapure water. A total of 500 μL PCR-amplified double-stranded product was added to streptavidin–agarose beads washed by PBS, and the sample was then incubated for 1 h at room temperature on a rotating mixer. After centrifugation and washing, 500 μL of 200 mM NaOH was added to the precipitate, and the mixture was incubated at room temperature for 10 min. Then the sample was centrifuged at 5500 rpm for 3 min, and the free single-stranded DNA in the supernatant was collected. The single-stranded DNA was purified using a desalting column (GE Healthcare illustra NAP-5 column Sephadex G-25 DNA grade) as the secondary library for the next round of screening.
Counter selection: tosyl-activated magnetic beads are modified with reactive tosyl groups on their surface, which can undergo nucleophilic substitution reactions with the amino groups on the surface of the HSA [
37], forming stable covalent bonds and thereby enabling the immobilization of HSA on the magnetic bead surface, as shown in
Figure S9. Therefore, to eliminate aptamer sequences that non-specifically bind to HSA, after the 4th round of screening, the conditional control group of HSA-modified tosyl-activated magnetic beads was used for counter-selection every 2 rounds. Specifically, HSA-modified tosyl-activated magnetic beads were incubated with the secondary library at 25 °C for 60 min. Sequences with non-specific binding to HSA were captured by the magnetic beads, while α-amanitin-specific aptamers remained in the supernatant. The supernatant was then subjected to the same amplification–enrichment–purification steps as the secondary library. Then the supernatant was taken to the same amplification–enrichment–purification steps as the secondary library. These rounds were repeated 14 times to discover nucleic acid aptamers with high affinity.
However, the target-immobilized SELEX may suffer from hindrance caused by target immobilization on beads, which reduces the aptamers’ affinity. It should be noted that conventional single-target-immobilized SELEX has inherent limitations: target-immobilized SELEX is prone to steric hindrance that may alter the natural conformation of α-amanitin and block its binding sites, thereby reducing the affinity of the screened aptamers; while library-immobilized SELEX alone is likely to cause non-specific binding between the DNA library and magnetic beads, leading to false positive enrichment. Therefore, we continued to employ the library-immobilized SELEX for further selection. This approach avoids alterations to the target’s natural structure or blockage of its binding sites caused by chemical modification, which in turn effectively improves the specificity and affinity of the candidate aptamers by ensuring that the target maintains its native conformation during the screening process.
For library-immobilized SELEX, a new combinatorial library was created by combining a new random library sequence (5′-GGGGAGCTCAGAATAAACGCAA-35N-TTCGACATGAG-3′GCCCGGATC) with a library initially screened from target-immobilized SELEX. A total of 68 μL of 10 μM biotin-labeled capture strand (5′-TTGAGCGTTTATTCTGAGCTCCC-biotin) was hybridized with 500 μL of the combinatorial library. Then, the combinatorial library was coupled to streptavidin-coated magnetic beads through a biotin–avidin interaction, by incubating 400 µL cleaned streptavidin-modified magnetic beads and 500 µL hybridized strands at 25 °C for 1 h with gentle shaking. Then, the library beads were washed to remove unfixed library complementary strands. At each wash, the library beads were transferred to a new DNA Lo-Bind tube. After cleaning, the library beads were obtained. Subsequently, 200 μL of 1× TES buffer was added to the library beads, and the mixture was incubated at 25 °C for 60 min. The supernatant was discarded by magnetic separation to remove released strands without the presence of the target. The target α-amanitin and the library beads were incubated at room temperature for 60 min, after which the supernatant was collected as the library target. A sum of 10 μL of the library target was used as a template for PCR amplification (the PCR amplification and cycling conditions were the same as the target-immobilized SELEX). Next, the PCR products were immobilized on the cleaned streptavidin–agarose beads and subjected to alkaline treatment to prepare ssDNA. After desalting, secondary libraries were obtained (the experimental method was the same as the target-immobilized SELEX). Finally, α-amanitin aptamers with high affinity were obtained after multiple rounds of screening.
This combined strategy combines the advantages of both approaches: the target-immobilized SELEX ensures the preliminary enrichment of α-amanitin-specific aptamer candidates with high abundance, while the library-immobilized SELEX makes up for the defects of target immobilization and improves the affinity and specificity of the candidates. It effectively overcomes the drawbacks of single SELEX and ensures the screening of high-affinity α-amanitin-specific aptamers.
4.3. Sequencing and Structure Prediction of the Sequences
The single-stranded DNA (ssDNA) obtained from nucleic acid aptamer screening was then PCR amplified, and high-throughput sequencing analysis was performed of the ssDNA sequences using the Illumina HiSeq 2000 sequencer platform (Illumina, Inc., San Diego, CA, USA) to determine the enriched nucleic acid aptamer sequences. As a result of sequencing, FastQ files were generated using QIIME2 v2019.7, the quality was checked with FastQ, and a reliability analysis of the sequencing results was carried out. The top 20 sequences with the highest degree of homology were selected using MEGA X software. Repeated sequences were classified according to their similarity; a black shaded background indicates 100% homology, whereas gray shaded backgrounds indicate > 50% homology.
Excessively long aptamer sequences with significant spatial site resistance readily impact the binding of the aptamer to the target. Moreover, an overly long aptamer is not beneficial for design and practical applications, as it raises the synthesis cost. Therefore, in this study, the secondary structure of the α-amanitin aptamer was simulated using mFold software. The secondary structure of both random sequence and fixed sequence was simulated, which were classified according to the similarity of secondary structure. Homology analysis and secondary structure prediction were employed for the selection of sequences, and five sequences, 14-1, 14-14, 14-2, 14-3, and 14-6, were finally selected for further investigation.
4.4. Aptamers Affinity Test
The affinity of the nucleic acid aptamers was expressed in the dissociation constant (K
d), which was calculated using the Langmuir isothermal binding model through the equation:
A is the concentration of nucleic acid, T is the concentration of α-amanitin, and B represents the concentration of the library target; free α-amanitin binds the aptamers, causing the aptamers to dissociate from the immobilized beads and remain in the supernatant, whose concentration is then determined for subsequent analysis [
32]. All affinity measurements were performed in three independent experiments. Non-linearity was evaluated by calculation of the regression equations through the method of least squares for each curve. Error bars represented as mean ± standard deviation (SD) to reflect experimental reproducibility.
Before the experiment, the concentrations of the candidate aptamers and α-amanitin were determined using a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) with the Nucleic Acid mode and Protein mode, respectively. A total of 100 μL of 10 μM candidate aptamers was incubated with 206 μL of washed streptavidin-coated magnetic beads conjugated with the capture strand to obtain the library beads. Then, 150 μL of 20 μM α-amanitin was mixed thoroughly with the washed library beads, and the mixture was incubated on a rotating shaker at 25 °C for 60 min. After incubation, the tube was placed on a magnetic stand for 2 min, and the supernatant was collected for the determination of the library-target concentration. The concentration of the library target was determined using the Nucleic Acid mode. All of the experiments were performed in triplicate to ensure data accuracy, and the average of the triplicate data was used for the analysis.
4.5. Aptamers Specificity Test
In order to test the specificity of aptamer Seq78-4 for α-amanitin, three groups were set up: target α-amanitin group A, control group B (the target human serum protein (HSA)), and blank control group C (the target 1× binding buffer). The concentrations of the aptamer before their incubation with A, B, and C groups on the magnetic beads were recorded as A1, B1, and C1, respectively, and the concentrations of the aptamer after incubation with the target were recorded as A2, B2, and C2, respectively. The concentration differences among the three groups (the differences between A1 and A2, B1 and B2, and C1 and C2) were compared.
Firstly, the library was coupled to streptavidin-modified magnetic beads through biotin–avidin interaction. Next, 200 μL 1× TES buffers were incubated with library beads at 25 °C for 60 min. After magnetic separation, 200 μL supernatant was retained for the nucleic acid concentration measurement. Finally, the targets α-amanitin, HSA, and 1× binding buffer were separately incubated with library beads for 60 min at room temperature. The supernatant was taken for measurement after magnetic separation. To ensure data accuracy, each datum was measured three times to obtain the average value.
4.6. Serum and Temperature Stability of Seq784
The aptamer Seq-78-4 was incubated in a 25-fold diluted artificial serum to evaluate its serum stability and temperature stability, respectively. For serum stability assessment, the aptamer was incubated at room temperature for 0, 30, 60, and 120 min. For temperature stability assessment, it was incubated at 27 and 37 °C for 30 min, respectively. All samples were separated by 3% agarose gel electrophoresis, and the degradation of the aptamer was observed using a gel imaging system.
4.7. Sample Preparation and Extraction
A series of different concentrations (0 nM, 1 nM,10 nM, 25 nM, 50 nM, 75 nM, 100 nM, and 125 nM) of α-amanitin was applied onto the surface of tosyl-activated magnetic beads to form α-amanitin beads, and then incubated with an equal amount of Seq78-4 in TES buffer and artificial serum. After magnetic separation, the supernatant was collected to detect the Seq78-4 concentration. As the concentration of α-amanitin in the system decreased, the amount of Seq78-4 bound to α-amanitin decreased, and the concentration of unbound Seq78-4 in the supernatant increased accordingly. The binding rate was calculated as follows:
A0 represents the initial concentration of aptamer Seq78-4, and A denotes the concentration of aptamer Seq78-4 in the supernatant after incubation. The minimum detection limit is defined as the concentration of analyte that inhibits the binding observed at zero analyte by a significant level, in excess of 3SD values.
Accuracy was assessed by determining the recovery of samples (blank artificial serum) spiked with three levels of standard α-amanitin solutions. Precision was assessed by the relative standard deviation (RSD) of the recovery of three replicates.